コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 enates rather than carboxylates ribulose-1,5-bisphosphate.
2 oteins that deplete phosphatidylinositol 4,5-bisphosphate.
3 the PFK-1 allosteric activator fructose 2,6-bisphosphate.
4 omology domain with phosphatidylinositol 4,5-bisphosphate.
5 in the presence of phosphatidylinositol 4,5-bisphosphate.
6 ge of the CO2 acceptor molecule ribulose 1,5-bisphosphate.
7 sphatidylserine and phosphatidylinositol 4,5-bisphosphate.
8 hannel activated by phosphatidylinositol 3,5-bisphosphate.
9 tol-3-phosphate and phosphatidylinositol-3,5-bisphosphate.
10 e, forming the much more stable fructose 1,6-bisphosphate.
11 itol-5-phosphate to phosphatidylinositol-4,5-bisphosphate.
12 phates, including its substrate ribulose 1,5-bisphosphate.
13 the signaling lipid phosphatidylinositol-4,5-bisphosphate.
14 verting fructose-6-phosphate to fructose-1,6-bisphosphate.
15 to glucose 6-phosphate via beta-glucose 1,6-bisphosphate.
17 ast in part through phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) activation and linked to an
18 ysiological signal, phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) activity, indeed regulates
20 g components of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/AKT signalling cascade that
23 , a key effector of phosphatidylinositol-4,5-bisphosphate 3-kinase 1A, was previously implicated in C
24 ic mutations in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic (PIK3CA) subunit are mor
25 nse mutation in the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha (PIK3CA) g
26 replicated PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta) sites wer
27 Pik3cg, encoding phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma (Pi3kgamma
28 ls, and blockage of phosphatidylinositol-4,5-bisphosphate 3-kinase, Akt, or p38 downstream mitogen-ac
29 ear factor kappa B, phosphatidylinositol-4,5-bisphosphate 3-kinase/Akt, and p38 signaling pathways.
32 ions activating the phosphatidylinositol-4,5-bisphosphate-3-kinase (PI3K)-protein kinase B (AKT)-mamm
33 am molecule FIG4 (phosphatidylinositol (3,5)-bisphosphate 5-phosphatase) as significantly up-regulate
34 ttack on the aldehyde and yield tagatose 1,6-bisphosphate, a competitive inhibitor of the enzyme.
35 ro-glycolytic enzyme that forms fructose-2,6-bisphosphate, a powerful allosteric activator of 6-phosp
37 targets were the glycolytic enzymes fructose bisphosphate aldolase (FBPA) and glyceraldehyde-3-phosph
40 phosphate (S7P) to SBP, after which fructose-bisphosphate aldolase cleaves SBP into dihydroxyacetone
43 ing bifunctional unidirectional fructose 1,6-bisphosphate aldolase/phosphatase, have been identified.
44 y identified enzymes generate mevalonate 3,5-bisphosphate and a new decarboxylase we describe here, m
45 mitoyl-sn-glycero-3-phosphatidylinositol-4,5-bisphosphate and Atto488-1,2-dipalmitoyl-sn-glycero-3-ph
46 spholipid vesicles, phosphatidylinositol 4,5-bisphosphate and Ca(2+), or by the identity of the fluor
47 s in the absence of phosphatidylinositol 4,5-bisphosphate and is facilitated by palmitoylation of a s
48 interaction with phosphatidylinositol-(4,5)-bisphosphate and its subsequent cleavage from the precur
50 c binding of SVB to phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphat
51 t whereas levels of phosphatidylinositol-3,4-bisphosphate and phosphatidylinositol-3,4,5-trisphosphat
52 substrates, bicarbonate, CO(2) and ribulose bisphosphate and the product 3-phosphoglycerate associat
53 nase that generates phosphatidylinositol-3,5-bisphosphate and, directly or indirectly, phosphatidylin
54 te and its product phosphatidylinositol 3, 5-bisphosphate, and a WIPI-binding protein, ATG2A, but do
56 sitol 4,5-bisphosphate, 3-phosphate, and 3,5-bisphosphate are commonly considered as hallmarks of the
57 nd accumulation of phosphatidylinositol(3,4)-bisphosphate at invadopodia is a key determinant for inv
58 ature involving the phosphatidylinositol 4,5-bisphosphate binding residue (L1008), but was independen
59 ility studies, demonstrate that fructose 1,6-bisphosphate binding to the allosteric domain causes a s
61 with GTP-bound RAP1 and phosphoinositol 4,5 bisphosphate but this interaction is inhibited by the N-
63 the cbbL genes (67%-82%) coding the ribulose-bisphosphate carboxylase large chain in the Calvin cycle
64 arboxysomes are BMCs containing ribulose-1,5-bisphosphate carboxylase oxygenase and carbonic anhydras
65 (LHCA1, LHCB1, and LHCB4), the ribulose 1.5-bisphosphate carboxylase subunits (rbcL and RbcS), and e
67 carbon dioxide may be fixed via the ribulose bisphosphate carboxylase, Wood-Ljungdahl pathway or redu
68 ize toxic glycolate formed when ribulose-1,5-bisphosphate carboxylase-oxygenase oxygenates rather tha
69 ry of nearly 100 genes encoding ribulose-1,5 bisphosphate carboxylase-oxygenase subunit proteins of t
70 ound many copies of the enzymes ribulose 1,5-bisphosphate carboxylase/ oxygenase and carbonic anhydra
72 e two key carboxysomal enzymes, ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) and carboni
73 tosynthetic CO(2) fixing enzyme ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) forms dead-
74 trates the carbon-fixing enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) in a paracr
76 hotosynthetic CO2-fixing enzyme ribulose 1,5-bisphosphate carboxylase/oxygenase (rubisco) is inhibite
79 encies of the CO2-fixing enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) often limit
80 uester the CO(2)-fixing enzymes ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) to enhance
81 ymes, and immunolocalization of ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) to show tha
82 mes compartmentalize the enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) with carbon
83 ate, phosphate dikinase (PPDK), ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO), and phosph
84 The key enzyme of the CBB cycle, ribulose-bisphosphate carboxylase/oxygenase (RubisCO), is a main
85 O2 concentration at the site of ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco), simultaneo
91 nservation of Mg(2+) within the ribulose-1,5-bisphosphate carboxylase/oxygenase family of enzymes.
94 he CO(2)-fixing enzyme Rubisco (ribulose 1,5-bisphosphate carboxylase/oxygenase) to release tightly b
95 e carbon-fixing enzyme Rubisco (ribulose-1,5-bisphosphate carboxylase/oxygenase), a major component o
96 boxylase, class II aldolase, or ribulose 1,5-bisphosphate carboxylase/oxygenase, large subunit (RuBis
98 to model maximal rates of RuBP (ribulose-1,5-bisphosphate) carboxylation (Vcmax ) and electron transp
99 urthermore, we report the INPP1/inositol 1,4-bisphosphate complex which illuminates key features of t
100 carboxylase we describe here, mevalonate 3,5-bisphosphate decarboxylase, produces isopentenyl phospha
101 maturation through phosphatidylinositol-3,5-bisphosphate-dependent activation of TRPML1, whereas che
102 macropinosomes in a phosphatidylinositol 3,5-bisphosphate-dependent manner and localize to their cont
103 Rac1-dependent and phosphatidylinositol 4,5-bisphosphate-dependent signaling cascade that suppresses
104 ing by mutations or phosphatidylinositol 4,5-bisphosphate depletion, we show that KCNE1 affects both
105 echanism whereby the binding of fructose 1,6-bisphosphate destabilizes an alpha-helix that bridges th
106 nzyme that produces phosphatidylinositol 4,5-bisphosphate, directly interacts with Rab7a and plays cr
108 membrane containing phosphatidylinositol 4,5 bisphosphate, even if phosphatidylserine (PS) is present
110 We show that the PKM2 activator fructose 1,6-bisphosphate (FBP) alone promotes tetramerisation and in
111 tructural reorganization of the fructose 1,6-bisphosphate (FBP), an allosteric activator, binding sit
113 ation by sensing the absence of fructose-1,6-bisphosphate (FBP), with AMPK being progressively activa
114 tor alanine (Ala) and activator fructose-1,6-bisphosphate (Fru-1,6-BP) in human liver pyruvate kinase
116 phosphorylating agents, such as fructose 1,6-bisphosphate, generate phosphorylated forms of both conf
117 ure is required for phosphatidylinositol 4,5-bisphosphate homeostasis mediated by Nir2 at ER-PM junct
118 the continuous accumulation of fructose 1,6-bisphosphate in a permanently frozen solution as followe
121 ith the fluorescent phosphatidylinositol 4,5-bisphosphate/inositol 1,4,5-trisphosphate biosensor GFP-
123 ozymes to hydrolyze phosphatidylinositol 4,5-bisphosphate into the second messengers diacylglycerol a
124 detect inositol phosphate (IP), inositol 4,5-bisphosphate (IP2 ), inositol 1,4,5-trisphosphate (IP3 )
126 al phosphoinositide phosphatidylinositol-3,5-bisphosphate, is an essential regulator of lysosomal bio
127 els of the allosteric regulator fructose-2,6-bisphosphate, leading to increased glycolytic activity b
128 binding of ENTH to phosphatidylinositol 4,5-bisphosphate leads to a substantial increase in adhesion
129 A and protein levels as well as fructose-2,6-bisphosphate levels were increased in aLivGHRkd mice, su
130 find clustering of phosphatidylinositol 4,5-bisphosphate-like lipids that induce a directional membr
131 When we include phosphatidylinositol 4,5-bisphosphate-like lipids that preferentially interact wi
132 117 mumol CO2 m(-2) s(-1)) and ribulose-1:5-bisphosphate limited carboxylation rate (Jmax 213 mumol
134 of plasma membrane phosphatidylinositol 4,5-bisphosphate microdomains at nascent sheaths, followed b
135 nolayers containing phosphatidylinositol-4,5-bisphosphate, mimicking presence of this phosphoinositid
136 ition, we observe a phosphatidylinositol-4,5-bisphosphate molecule forming a bridge between the membr
137 ntamer contains two phosphatidylinositol-4,5-bisphosphate molecules, the head groups of which occupy
138 phosphoinositide phosphatidylinositol (4,5)-bisphosphate or altered the subcellular localization of
139 lective SND1 inhibitor 3', 5'-deoxythymidine bisphosphate (pdTp), inhibited tumor formation without e
141 sicular signaling lipid phosphatidylinositol bisphosphate PI(3,5)P2 modulates TPC2 activity to contro
142 to accumulation of phosphatidylinositol 4,5-bisphosphate PI(4,5)P2 in endolysosomes, driving local h
143 The membrane lipid phosphatidylinositol-3,4-bisphosphate (PI(3,4)P(2)) is an important signaling eff
144 lipid messenger, phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P(2)), are not well understood.
146 e (PI(3,4,5)P3) and phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2), suggesting that the macropinos
147 this, the effect of phosphatidylinositol 3,5-bisphosphate (PI(3,5)P(2)) on vacuole fusion remains unk
149 al signaling lipid, phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), is required for full assembly
150 teins interact with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) and are either activated or i
151 oinositides (PIPs), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) and phosphatidylinositol 3,4-
152 ) channel-dependent phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) compartmentalization governs
153 ther explaining how phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) influences ENaC activity and,
156 RTKs can hydrolyze phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) within the nucleus, leading t
157 phosphates, such as phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)), are enriched at the cell sur
161 generated elevated phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and reduced phosphatidylinosito
163 omote hydrolysis of phosphatidylinositol 4,5 bisphosphate (PI(4,5)P2) by functioning with synaptojani
166 e C (PLC)s degrade phosphatidylinositol-4, 5-bisphosphate (PI(4,5)P2) lipids and regulate multiple ce
168 to the phospholipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), a marker for the plasma membra
169 he phosphoinositide phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), and Tec kinase, as well as mem
170 tion of Ca(2+) with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), the main lipid marker of the p
171 y the tubby domain in a phosphoinositide 4,5-bisphosphate (PI(4,5)P2)-dependent manner, ciliary deliv
172 Regulated by phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P2)-levels, myelin septins (SEPT2/S
175 er, steady-state PM phosphatidylinositol 4,5-bisphosphate (PI[4,5]P2) levels, important for localizat
176 5-trisphosphate and phosphatidylinositol-3,4-bisphosphate [PI(3,4)P2] and consequently recruit plecks
177 the signaling lipid phosphatidylinositol-3,5-bisphosphate [PI(3,5)P2] is required in neurons and in O
180 robust decrease in phosphatidylinositol 4,5-bisphosphate [PI(4,5)P(2)] levels, which is a major cont
181 the synthesis of phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P(2)], a key regulator of dynamic e
185 llular host factors phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and ubiquitin for its activatio
187 osphoinositide phosphatidylinositol (PI) 4,5-bisphosphate [PI(4,5)P2] is a well-known precursor for i
190 of plasma membrane phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] leads to a decrease in exocytos
191 EM24 transports the phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] precursor phosphatidylinositol
192 pha to synthesize phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P2] rather than to remove PI5P.
193 R) interacts with phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P2], a PM-specific acidic lipid.
194 by its binding to phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P2], and MA binding to cellular RNA
195 sitides, especially phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], regulate the activities of man
202 through hydrolysing phosphatidylinositol 4,5-bisphosphate (PIP(2) ) to produce the initial proton sig
203 odally regulated by phosphatidylinositol 4,5-bisphosphate (PIP(2) ), the substrate hydrolysed by PLC,
206 membrane lipids: Phosphatidylinositol (4, 5)-bisphosphate (PIP(2)) activates the channel; a secondary
208 ng carboxy-terminal phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding domains, or the entire C t
210 identify a unique phosphatidylinositol (4,5)-bisphosphate (PIP(2)) interaction profile near intracell
211 that is promoted by phosphatidylinositol 4,5-bisphosphate (PIP(2)) is also phosphorylation-dependent,
212 that cannot bind to phosphatidylinositol 4,5-bisphosphate (PIP(2)) or that constitutively adopt a clo
213 mbrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP(2)) regulates the activity of diverse
214 Here we show that phosphatidylinositol (4,5)-bisphosphate (PIP(2)) regulates TMEM16A channel activati
215 h direct binding of phosphatidylinositol 4,5-bisphosphate (PIP(2)) stabilized the oligomers, the stab
216 ptors both consumes phosphatidylinositol 4,5-bisphosphate (PIP(2)) via phosphalipase Cbeta hydrolysis
217 s liposomes lacking phosphatidylinositol-4,5-bisphosphate (PIP(2)) with greater Ca(2+) sensitivity th
218 ation by increasing phosphatidylinositol 4,5-bisphosphate (PIP(2)), and our molecular dynamics simula
219 asma membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP(2)), but it is unclear whether PIP(2)
220 and membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP(2)), but lack of structural informatio
221 he phospholipid, phosphatidylinositol (4, 5)-bisphosphate (PIP(2)), directly interacts with the DAT N
222 e phosphoinositide, phosphatidylinositol 4,5-bisphosphate (PIP(2)), has long been established as a ma
223 anes, in particular phosphatidylinositol 4,5-bisphosphate (PIP(2)), initially suggested they act as c
227 ated that the lipid phosphatidylinositol 4,5-bisphosphate (PIP2 ) enabled the slow AHP component (sAH
228 f1/Brag2 complex with a phosphatidylinositol bisphosphate (PIP2) -containing lipid bilayer, using coa
229 nges in response to phosphatidylinositol-4,5-bisphosphate (PIP2) and cargo binding at multiple sites.
230 ion is dependent on phosphatidylinositol 4,5-bisphosphate (PIP2) and is related to SNARE complex form
231 lated with synaptic phosphatidylinositol 4,5-bisphosphate (PIP2) and that alterations in PIP2 at the
232 ivation of ezrin by phosphatidylinositol-4,5-bisphosphate (PIP2) binding and a threonine phosphorylat
234 C2B-SNAP25 and C2B-phosphatidylinositol 4,5-bisphosphate (PIP2) complexes, revealing how Rabphilin-3
235 ells showed an effect of phosphoinositol-4,5-bisphosphate (PIP2) depletion on MET current amplitude a
236 Galphaq activation, phosphatidylinositol 4,5-bisphosphate (PIP2) depletion, and diacylglycerol produc
239 d redistribution of phosphatidylinositol 4,5-bisphosphate (PIP2) from the plasma membrane to actin ri
240 the membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2) is a potent inhibitory gating modifi
244 dies that suggested that phosphoinositol-4,5-bisphosphate (PIP2) only induces vinculin homodimers, wh
246 constitutive lipid phosphatidylinositol-4,5-bisphosphate (PIP2) to produce the signaling lipid phosp
247 d, cardiolipin, and phosphatidylinositol 4,5-bisphosphate (PIP2)) PLs containing palmitoyl-oleoyl and
248 e common gating ligand, phosphatidylinositol bisphosphate (PIP2), although these exhibit opposite cou
249 ete plasma membrane phosphatidylinositol 4,5-bisphosphate (PIP2), and these interactions provide a mo
250 almodulin (CaM) and phosphatidylinositol-4,5-bisphosphate (PIP2), but the role of CaM in channel func
252 itides, including phosphatidylinositol-(4,5)-bisphosphate (PIP2), resulting in VEGF-exacerbated defec
253 by PLC breakdown of phosphatidylinositol 4,5-bisphosphate (PIP2), the mechanism by which the PLC path
254 yo-inositol-derived phosphatidylinositol 4,5-bisphosphate (PIP2), the mechanisms and functional conse
255 mbrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2), the source of the Ca(2+)-releasing
256 MARCKS) and release phosphatidylinositol-4,5-bisphosphate (PIP2), thereby stimulating production of t
257 tingent on membrane phosphatidylinositol 4,5-bisphosphate (PIP2), which is fundamental for maintainin
258 ugmented in vivo by phosphatidylinositol 4,5-bisphosphate (PIP2), which is generated from myo-inosito
259 sts, we noticed the phosphatidylinositol 4,5-bisphosphate (PIP2)-binding protein, myristoylated alani
260 cluded by screening phosphatidylinositol 4,5-bisphosphate (PIP2)-negative charges with poly-l-lysine
263 -C2gamma produces a phosphatidylinositol-3,4-bisphosphate pool specifically required for delayed and
264 llular clathrin and phosphatidylinositol-3,4-bisphosphate predict the excitability of the plasma memb
265 es identified are metabolism of fructose-1,6-bisphosphate, production of glycerol-3-phosphate and com
266 mechanism whereby the levels of fructose 2,6-bisphosphate promote mitochondrial PDK4 levels and ident
267 ucture reveals that phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P2) binds to the N terminus of
268 ed signalling lipid phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P2), whereas other phosphoinosi
270 calcium-activated, phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) -modulated, non-selective c
272 serine (PtdSer) and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) have been implicated in the
273 an enzyme producing phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), stabilizes Mig6 expression
276 latory phospholipid phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] is critical for polar tip g
279 but a single lipid (phosphatidylinositol-4,5-bisphosphate) regulates many LPS responses, including en
281 that functions to scavenge the ribulose-1,5-bisphosphate (RuBP) by-product of purine/pyrimidine meta
283 addition of CO(2) onto enolized ribulose 1,5-bisphosphate (RuBP), producing 3-phosphoglycerate which
286 tic clostridia rely on the sedoheptulose 1,7-bisphosphate (SBP) pathway, using pyrophosphate-dependen
287 ly highly organized phosphatidylinositol-4,5-bisphosphate signaling program required for establishmen
289 pathways, including phosphatidylinositol-3,5-bisphosphate synthesis and retrograde transport from the
291 isoforms hydrolyze phosphatidylinositol 4,5-bisphosphate to the second messengers inositol 1,4,5-tri
292 presence of 2.5 mum phosphatidylinositol 4,5-bisphosphate, TRPV1 channels demonstrated rapid activati
294 replace radioactive phosphatidylinositol 4,5-bisphosphate used in conventional PLC assays and will en
295 membrane-localized phosphatidylinositol-4,5-bisphosphate using the pleckstrin-homology domain (PHD)
297 he regulatory lipid phosphatidylinositol 4,5-bisphosphate was enriched at sites of cell wall invagina
298 Pfk2 catalyzes the synthesis of fructose-2,6-bisphosphate, which acts as a potent allosteric activato
299 res inhibition by the regulator fructose 1,6-bisphosphate, which senses the upper-glycolytic flux and
300 , the reaction intermediate beta-glucose 1,6-bisphosphate, whose concentration depends on the beta-gl